Curet Myriam - Jan 25, 2022 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
EVP & Chief Medical Officer
Signature
By: Donna Spinola For: Myriam Curet
Stock symbol
ISRG
Transactions as of
Jan 25, 2022
Transactions value $
-$836,636
Form type
4
Date filed
1/26/2022, 05:26 PM
Previous filing
Jan 4, 2022
Next filing
Feb 17, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $419K +3K +1052.63% $139.52 3.29K Jan 25, 2022 Direct F1
transaction ISRG Common Stock Sale -$792K -3K -91.32% $263.94 285 Jan 25, 2022 Direct F1, F2
transaction ISRG Common Stock Options Exercise $328K +3K +1052.63% $109.49 3.29K Jan 25, 2022 Direct F1
transaction ISRG Common Stock Sale -$792K -3K -91.32% $263.94 285 Jan 25, 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -3K -100% $0.00* 0 Jan 25, 2022 Common Stock 3K $109.49 Direct F1, F3
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -3K -16.67% $0.00 15K Jan 25, 2022 Common Stock 3K $139.52 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were exercised and sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 9, 2022.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $261.60 to $266.71 as follows: 953 shares sold at $261.60 to $261.67; 1,447 shares sold at $262.30 to $262.80; 900 shares sold at $263.12 to $263.20; 829 shares sold at $264.575 to $265.44; 671 shares sold at $265.44 to 265.74, and 1,200 shares sold at $266,11 to $266.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
F4 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.